Risk factors and diagnosis of diabetic foot ulceration in users of the Brazilian public health system by Cardoso, Hígor Chagas et al.
Research Article
Risk Factors and Diagnosis of Diabetic Foot Ulceration in
Users of the Brazilian Public Health System
Hígor Chagas Cardoso ,1 Ana Laura de Sene Amâncio Zara ,2
Suélia de Siqueira Rodrigues Fleury Rosa,3 Gabriel Alves Rocha ,4
João Victor Costa Rocha ,4 Maria Clara Emos de Araújo,4 Pedro de Freitas Quinzani ,4
Yaman Paula Barbosa ,4 and Fátima Mrué 1
1Postgraduate Program of Health Sciences, Federal University of Góias, Goiânia, Goiás 75605-050, Brazil
2Postgraduate Program of Odontology, Federal University of Góias, Goiânia, Goiás 74605-220, Brazil
3Postgraduate Program of Biomedical Engineering (FGA), University of Brasília, Brasília, Distrito Federal 72444-240, Brazil
4Undergraduate Program of Medicine, University Center of Anápolis Unievangélica, Anápolis, Goiás 75075-010, Brazil
Correspondence should be addressed to Hígor Chagas Cardoso; medhigor@gmail.com
Received 19 April 2019; Revised 3 July 2019; Accepted 10 July 2019; Published 9 September 2019
Guest Editor: Zhihong Peng
Copyright © 2019 Hígor Chagas Cardoso et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Background. An individual with diabetes mellitus (DM) has an approximately 25% risk of developing ulcerations and/or
destruction of the feet’s soft tissues. These wounds represent approximately 20% of all causes of hospitalizations due to DM.
Objective. To identify the factors for the development of diabetic foot ulceration (DFU) among individuals treated by the
Brazilian public health system. Methods. This cross-sectional study was conducted on individuals with diabetes mellitus, aged
above 18 years, of both sexes, and during July-October 2018 within a public healthcare unit in Brazil. All participants were
assessed based on their socioeconomic, behavioral, and clinical characteristics, along with vascular and neurological evaluations.
All participants were also classified according to the classification of risk of developing DFU, in accordance with the
International Working Group on the Diabetic Foot (IWGDF). Statistical analyses were conducted using the chi-squared test,
chi-squared test for trend, and Fisher’s exact test, with a significance level of 5% (p < 0 05). Results. The study consisted of 85
individuals. The DFU condition was prevalent in 10.6% of the participants. Adopting the classification proposed by IWGDF,
observed risks for stratification categories 0, 1, 2, and 3 were 28.2%, 29.4%, 23.5%, and 8.2%, respectively. A statistically
significant (p < 0 05) association was observed between the development of DFU and the following variables: time since the
diagnosis of diabetes and the appearance of the nails, humidity, and deformations on the feet. Conclusion. The present study
found an elevated predominance of DM patients in the Brazilian public health system (SUS) featuring cutaneous alterations that
may lead to ulcers; these individuals had elevated risks of developing DFU. Furthermore, it was revealed that the feet of patients
were not physically examined during treatment.
1. Introduction
Diabetes mellitus (DM) is a metabolic disturbance resulting
from constant hyperglycemia due to modifications in the
production and/or the action of insulin. DM affects approxi-
mately 425 million people worldwide [1].
In 2017, Brazil, with an estimated population of 12.5 mil-
lion diabetic individuals, was classified as among the 4 coun-
tries with the highest numbers of individuals with diabetes in
the world. The predicted financial costs on treatment and
prevention of diabetes in Brazil was found to be roughly
US$ 15.7 billion in 2017 [1]. In the state of Goiás, where
the current study was conducted, the expenditure on hospital
treatment for diabetes amounted to US$ 700,000.00 [2].
A series of factors such as the lack awareness of the dis-
ease by both the population and health professionals, low
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efficiency of health services, and the undercover primary
characteristics of the disease, lead to the late diagnosis of
DM complications. An estimated 46.0% of occurrences in
adults are not diagnosed, where 83.8% of these cases happen
in developing countries [3].
The ulceration and/or destruction of soft tissue of the feet
of individuals with diabetes characterize a clinical condition
commonly known as the diabetic foot ulceration (DFU),
responsible for 20% of all hospitalizations of people with
DM [4, 5]. This condition is associated with neurological
alterations and peripheral arterial disease (PAD), indepen-
dent of any related infection. A person with DM is estimated
to have a risk of about 25% of developing the DFU condition
during his/her lifetime [4, 5]. The direct medical costs related
with the treatment of DFU in Brazil was estimated to be US$
180 million in 2014 [6].
Considering the social and economic impacts of
DFU, few studies have considered the development of
simpler evaluation protocols of easier applicability, aimed
at the prevention and minimization of the impact of this
clinical condition. These protocols are based on the eval-
uation of individuals diagnosed with or in high risk of
developing DFU.
Thus, the current study was aimed at identifying the
factors related to the development of DFU in individuals
treated by the primary healthcare network in a public unit
in Brazil in 2018. This paper is aimed at serving as a foun-
dation for the further development of protocols for the
diagnosis of DFU.
2. Materials and Methods
This cross-sectional study was conducted from July 11 to
October 18, 2018, at the Dr. Ilion Fleury Jr. Health Unit, a ref-
erence unit for basic healthcare where DM cases identified in
the primary healthcare network are forwarded to, within the
county of Anápolis, state of Goiás, Brazil.
The probabilistic sample was estimated by means of the
OpenEpi® program, version 22. To calculate the sample size,
a total population of 600 patients with type 2 DM diagnosed
during the 3-month study period was considered, with a
prevalence of 50% of at least 1 risk for ulceration [7], an accu-
racy of 10%, and a confidence level of 95%. A sample of
approximately 82 participants was estimated as follows:
n = Np 1 − p
d2/Z2 1 − α /2 ∗ N − 1 + p ∗ 1 − p , 1
where N is the population size (in this case, 600), p is the
expected proportion of the event (in this case, 50%), d is
precision (in this case, 10%), Z is the standard score of
the normal distribution (in this case, 1.96), and α is 5%.
During the study period, the sample size was increased to
85 patients diagnosed with type 2 DM undergoing treatment
at that health facility. All patients were at least 18 years old
and from both genders, needed drug treatment, and had been
monitored by endocrinologists.
Five participants were excluded from the study because
they had communicative or neurological disorders unrelated
to DM that made it impossible for the patient to participate
in the interview or limited the responses to the sensory stim-
uli in their feet during the clinical evaluations.
Questionnaires were used to collect data by gathering
information from the Brazilian Society of Diabetes (SBD)
[8] and recent publications from the Ministry of Health
of Brazil [4, 5]. In the questionnaire, the variables on
socioeconomic identification and characterization were col-
lected based on the Brazil Economic Classification Criteria
from the Brazilian Market Research Association (ABEP)
[9], including variables related to anamnesis and previous
records of the disease. General, vascular, and neurological
evaluations of the patients’ feet were made through physi-
cal examinations. These analyses provided the classification
of the associated risk of developing DFU, a classification
system validated by the International Working Group on
the Diabetic Foot (IWGDF) [10] and used by the SBD,
through the diagnosis of the loss of protective sensation
(LOPS) and PAD.
In accordance to directives from SBD [8] and risk classi-
fication as proposed by IWGDF [10], LOPS was considered
in the cases that had altered tests of 10 g monofilament asso-
ciated with at least 1 altered neurological exam (vibratory
sensation test using a 128Hz tuning fork, a pinprick sensa-
tion test using a disposable pin, and/or an ankle reflex test
using a tendon hammer).
The absence or reduction in size of dorsalis pedis and
posterior tibial pulses associated with the Ankle Brachial
Pressure Index ABI < 0 9 was considered as being conclu-
sive for PAD diagnosis and used as parameters for risk clas-
sification as proposed by IWGDF [10]. ABI was quantified
using a manual Doppler transducer of 8-10MHz, by calculat-
ing systolic pressures of the arm (brachial artery) and of the
ankle (anterior and posterior tibial arteries), followed by
relating the greatest values of the lower limbs with the great-
est value of the brachial artery [11].
Considering the IWGDF Risk Classification System, cat-
egory 0 featured individuals with DM and without LOPS and
PAD; category 1 featured individuals with LOPS regardless of
deformities on their feet, as indicated by physical examina-
tion; category 2 considered individuals evaluated with PAD
regardless of its association with LOPS; and category 3
encompassed individuals with DM where their medical his-
tory listed ulcerations or amputations [7, 10]. Individuals
diagnosed with the DFU condition were those who had any
type of unhealed ulceration or any destruction of soft tissue
on their feet.
Data were tabulated and further analyzed using the
programs Epi Info®, version 7.1 and IBM SPSS Statistics®,
version 22, respectively. Absolute (n) and percentage (%)
frequencies were used to describe categorical variables,
whereas standard deviation (SD), averages, and minimum
and maximum values were used to describe continuous
variables. The chi-squared test for trend was used for com-
parison of proportions. Fisher’s exact test was substituted for
the chi-squared test when the expected frequency was <5
in more than 20% of the table cells and/or table cells with
values <1. All statistical tests adopted a 5% (p < 0 05) sig-
nificance level.
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3. Ethical Considerations
This study was approved by the Research Ethics Committee
of the Federal University of Goiás, with the query response
number 2.504.169 on February 21, 2018.
4. Results and Discussion
4.1. Results. The sample consisted of 85 individuals whose age
varied between 20 and 93 years and averaged 59.6 years
(SD = ±12 8). Higher frequencies among participants were
observed in the following categories: female (64.7%), married
(48.2%), schooling up to elementary school diploma (37.6%),
and participants in economic classes C1 (37.6%) and C2
(30.6%) (Table 1).
Regarding the medical history of patients, the mean and
median diagnostic times for diabetes mellitus were 14.5 years
(SD = ±9 years) and 11 years (IIQ 25-75) (8-20), respectively.
Among the participants, 72.9% had relatives diagnosed with
DM and 76.5% of patients used insulin regularly (Table 2).
The diagnosis of PAD performed by identifying the alter-
ation in 1 of the peripheral pulses (dorsalis pedis or tibial
posterior) associated with the alteration of the ABI of 1 limb
was identified in 29.4% of the participants (Table 2).
The DFU condition was prevalent for 10.6% of the partic-
ipants. In the present study, based on the classification pro-
posed by IWGDF, the observed risks for stratification
category 0, 1, 2, and 3 were 28.2%, 29.4%, 23.5%, and 8.2%
of the patients, respectively (Table 3). A statistically signifi-
cant association was observed between the variables of med-
ical history of previous ulcerations and the diagnosis of LOPS
on the feet (p = 0 004) (Table 4).
The increased risk of developing DFU had statistically
significant associations with the following variables: time
since the diagnosis of diabetes mellitus (p = 0 037), altered
appearance of the nails (p = 0 019), altered humidity
(p = 0 029), and deformities on the feet (p < 0 001) (Table 5).
4.2. Discussion. A significant number of health professionals
associate the concept of DFU exclusively with the scenario
of an individual with diabetes that was further complicated
due to an infection on his/her foot. This association is not
correct and leads to slower diagnosis and slower adequate
treatment. Existing classifications consider situations of
infected wounds resulting from both neuropathy and ische-
mia, whereas treatments address patients with neuropathy
and plantar ulcers, independent of either superficial or deep
infections, and patients with critical ischemia in need of
revascularization [11].
In this study, while the majority of participants were
females, the average age was 59 years; these observations
were made at a reference unit of basic healthcare. More
women were diagnosed with DM than men, a fact that cor-
roborates the findings of the Brazilian National Health Sur-
vey in 2013 [12], which also found that most patients with
diabetes are above 60 years [12]. The higher number of older
women with diabetes on treatment within specialized health-
care units may be related to the greater life expectancy of
women than men, as well as the greater attention paid by
women on their health. Consequently, women may be found
to seek healthcare services more frequently, and thus, take
preventive measures, lowering their susceptibility to signifi-
cant complications such as DFU [13].
In Brazil, most (9.6%) patients diagnosed with DM had
no schooling and could not complete elementary school
[12]. In the current study, a higher frequency was observed
among those who had an incomplete elementary schooling
experience. As seen in other studies [14], the low schooling
levels complicated the access to information and learning
materials on diabetes, its prevention, and its complications.
This fact reveals the importance and relevance of socially
determined factors of diseases.
Regarding economic details, most of the individuals were
in class C. The frequency of this classification is similar to
that reported by Santos et al. [15]; these authors associated
net income, in terms of minimum wages, with amputation
rates of diabetic feet.
This research has shown that the length of time after
diagnosis of DM is associated with the risk levels of devel-
oping the DFU condition. Other research studies [8, 16, 17]
Table 1: Socioeconomic profiles of individuals with diabetes




















Junior high school diploma/incomplete high school 10 (11.8)
High school diploma/incomplete higher education 27 (31.8)
Higher education degree 3 (3.5)
Economic classification∗ (average monthly household
income in US$)
B1 (2,556) 3 (3.5)
B2 (1,326) 12 (14.1)
C1 (793) 32 (37.6)
C2 (543) 26 (30.6)
D (380) 11 (12.9)
E (380) 1 (1.2)
∗Source: Brazilian Market Research Association in 2014 [8].
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also established time evolution of the disease as a risk
factor for developing the complications of LOPS, PAD,
and DFU.
Previously diagnosed systemic arterial hypertension
(SAH) has also been found to be prevalent in DM patients
in this study. It must also be noted that SAH is considered
a risk factor for the development of other cardiovascular dis-
eases and for microvascular impairment, which may then
lead to peripheral neuropathy, retinopathy, and nephropathy
[8, 16–18].
Most participants in this study also reported treatment
of dyslipidemia, which is also considered a risk factor for
the development of atherosclerosis and consequently for
the development of cardiovascular diseases, such as PAD
[11]. Moreover, dyslipidemia is notoriously associated with
peripheral neuropathy, as seen in the work of Khawaja
et al. [19].
More than 80% of participants with DM in this study
reported ophthalmologic alterations. The progressive weak-
ening of vision is known as a consequence of diabetic reti-
nopathy, which leads to limited personal care of the
patient’s own feet, such as incomplete feet hygiene, a limited
inspection of plantar and interdigital regions, and inadequate
nail cutting [4, 5, 8]. Other studies [16, 17] have shown the
association between diabetic retinopathy and the develop-
ment of DFU.
Among the participants, only 30% were regularly
involved in physical activities, although it is commonly rec-
ommended for all patients with DM. A significant portion
of participants (21.2%), higher than in other similar studies
[20], was observed to have the habit of walking barefooted,
contrary to medical recommendations that consider individ-
uals with DM as more susceptible to lesions and amputations
of the lower limbs [4, 5, 8].
In order to prevent further disease complications, health-
care measures for patients with diabetes, such as general
informative orientations and evaluation of the feet of these
patients, are fundamental and must be executed by qualified
health professionals [4, 5, 8, 21]. However, only 28.2% of the
patients reported any form of feet evaluation by a health pro-
fessional, and only 31.8% reported receiving orientations
regarding the prevention of the DFU condition. Such worri-
some situations of ineffective provision and spread of preven-
tive measures for the disease were also noticed in previous
studies [8], which recommended the implementation of
interdisciplinary support protocols dedicated to the early
diagnosis and prevention of the DFU condition within basic
healthcare units.
The physical evaluation of the patients’ feet by a qualified
professional is essential, since more than 10% of the
Table 2: Clinical analysis of individuals with diabetes mellitus
treated at a reference unit of basic healthcare at Anápolis, Goiás,
Brazil, 2018.
Clinical characteristics
Average time since diagnosis of diabetes
(years) (±standard deviation) 14.5 (±9.0)
Medical history n (%)
Records of diabetes mellitus in the family 62 (72.9)
Previous use of oral hypoglycemic agents 53 (62.4)
Regular use of insulin 65 (76.5)
Systemic arterial hypertension 64 (75.3)
Dyslipidemia 57 (67.1)
Ophthalmologic alterations 72 (84.7)
Cardiovascular alterations 28 (32.9)
Smoking 41 (48.2)
The practice of physical activity 27 (31.8)
Barefoot walking habits 18 (21.2)
Feet examined by the health agent 24 (28.2)
Received feet healthcare orientations 27 (31.8)
Signs of ulceration on the feet 10 (11.8)
Pain when walking 66 (77.6)
Muscle weakness on the feet or other lower limbs 62 (72.9)
Any other diverse symptoms on the lower limbs 77 (90.6)
Physical evaluation
Adequate footwear 42 (49.4)
The appearance of the nails 65 (76.5)
Nails properly cut 38 (44.7)
Mycotic wounds on the feet 72 (84.7)
Altered skin appearance 81 (95.3)
Normal hair growth 20 (23.5)
Hyperkeratosis 80 (94.1)
Anhidrosis 66 (77.6)
Deformities on the feet 5 (5.6)
Previous amputations 10 (11.8)
Peripheral arterial disease (PAD) 25 (29.4)
Loss of protective sensation (LOPS) 50 (58.8)
Altered 10 g monofilament exam 55 (54.7)
Altered test of a 128Hz tuning fork 44 (51.7)
Table 3: IWGDF risk classification in individuals with diabetes
mellitus attended at a reference unit of basic healthcare at






Table 4: Association between the loss of protective sensation and
previous medical history of previous ulcerations on patients with
diabetes mellitus who attended a reference unit of basic healthcare
at Anápolis, Goiás, Brazil, 2018.
Medical history of
previous ulcerations
Loss of protective sensation
p value∗Yes (n = 50) No (n = 35)
n (%) n (%)
Yes 10 (100.0) —
0.004
No 40 (53.3) 35 (46.7)
∗Fisher’s exact test (p < 0 05).
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participants described any sort of ulcerations of the lower
limbs. The symptoms, as described by DM patients, such as
“pain while walking,” “nightly pain which lowers while walk-
ing,” “muscle weakness,” “sudden twinge,” “cramps,” or “dis-
comfort with the pressure of the blanket” may be suggestive
of neuropathic and/or angiopathic alterations, which must
be confirmed during neurological and vascular evaluations
during physical examinations [4, 5, 7, 8, 17].
The healthcare measures to be observed by patients with
diabetes included the cutting of the nails and wearing of foot-
wear, since these observations will allow the patients to
change their lifestyle accordingly, and thus prevent future
complications [21–23]. In this research, only 49.4% of the
participants used appropriate footwear and 44.7% properly
cut their nails. In the study by Cubas et al. in [24], only
15% of the participants were observed to use appropriate
footwear and 52.5% cut their nails properly. The difference
between the values of the current study and that of the latter
is most probably because Cubas et al. did not adhere to the
current directives [5, 8], which define appropriate footwear
as comfortable and closed, without hollow regions or irregu-
lar stitching.
Through physical examination, a statistically significant
association was observed between the risk level for the devel-
opment of DFU and the following variables: appearance of
the nails, humidity, and feet deformities. Alonso-Fernández
et al. [25] had also described such association (p < 0 01)
between the identification of feet deformities and DFU.
However, the high frequency of mycotic wounds (84.7%),
altered appearance of the skin (95.3%), and hyperkeratosis
(94.1%) had no statistically significant association with
DFU. These variables must be analyzed for DM patients,
for they are considered preulcerative conditions caused by
diabetic polyneuropathy and PAD [8, 10, 23].
This study identified a frequency of 29.4% of patients
with conditions suggesting PAD (altered pulse palpation
and ABI < 0 9), a similar value to that reported by Brito
et al. [26] of 28.5%, and smaller than that of the study of
Eurodiale [27], which was 50%. Conversely, these data can-
not be possibly compared to those of other Brazilian studies,
as most studies did not measure the ABI, although such
objective procedure is recommended by the Brazilian Society
of Diabetes [8], the Ministry of Health of Brazil [5], the
American Diabetes Association [28], and the Society for Vas-
cular Surgery [21]. A great number of Brazilian studies rely
only on pulse palpation [14], an unreliable method of evalu-
ation which may vary significantly depending on the
observer [11]. PAD diagnosis is important for the DM
patient, so as to implement the use of adequate footwear
and proper medical monitoring with a vascular specialist sur-
geon, preventing the progression of complications of the
DFU condition and its related high financial costs [29].
Table 5: IWGDF risk classification for the development of diabetic foot ulceration according to the clinical characteristics of individuals
diagnosed with diabetes mellitus at Anápolis, Goiás, Brazil, 2018.
Clinical characteristics
Category DFU∗
p value0 1 2 3
n (%) n (%) n (%) n (%) n (%)
Regular use of insulin
Yes 13 (20.0) 21 (32.3) 17 (26.2) 6 (9.2) 8 (12.3)
0.053§
No 11 (55.0) 4 (20.0) 3 (15.0) 1 (5.0) 1 (5.0)
Smoking
Yes 8 (19.5) 11 (26.8) 14 (34.1) 4 (9.8) 4 (9.8)
0.172§
No 16 (36.4) 14 (31.8) 6 (13.6) 3 (6.8) 5 (11.4)
Symptoms on the lower limbs
Yes 22 (28.6) 22 (28.6) 17 (22.1) 7 (9.1) 9 (11.7)
0.623§
No 2 (25.0) 3 (37.5) 3 (37.5) — —
Time since the diagnosis of diabetes (years)
0-10 13 (32.5) 13 (32.5) 8 (20.0) 2 (5.0) 4 (10.0)
0.037†11-20 9 (32.1) 9 (32.1) 6 (21.4) 3 (10.7) 1 (3.6)
21-40 2 (11.8) 3 (17.6) 6 (35.3) 2 (11.8) 4 (23.5)
Appearance of the nails
Normal 11 (55.0) 2 (10.0) 6 (30.0) 1 (5.0) —
0.019†
Altered 13 (20.0) 23 (35.4) 14 (21.5) 6 (9.2) 9 (13.8)
Humidity of the feet
Normal 5 (55.6) 3 (33.3) 1 (11.1) — —
0.029†
Altered 19 (25.0) 22 (28.9) 19 (25.0) 7 (9.2) 9 (11.8)
Deformities
Normal 24 (30.4) 25 (31.6) 20 (25.3) 4 (5.1) 6 (7.6) <0.001†
Altered — — — 3 (50.0) 3 (50.0)
∗DFU: diabetic foot ulceration. §Chi-squared test. †Chi-squared test for trend. p values in bold indicate statistically significant differences (p < 0 05).
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The examination of diabetic polyneuropathy must be ini-
tiated through the monofilament examination of a 10 g
monofilament [5, 8, 21, 28], which allows the detection of loss
of large fiber nerve function, related to protective plantar sen-
sation, with an estimated sensibility of 91% [6, 30]. About
54.7% of the participants had an altered monofilament exam,
according to current recommendations [5, 8, 21, 31]. How-
ever, it is not appropriate to compare the results to those of
other papers that performed the same examination, since
IWDGF [10] recommends the 10 g monofilament test to be
undertaken on only 3 regions (1st, 3rd, and 5th metatarsal
heads); however, other Brazilian studies performed the
examination on 9 distinct locations of the feet [14].
To diagnose LOPS, a complementary examination of
vibratory sensations (using a tuning fork of 128Hz), pinprick
sensation, and ankle reflexes, were conducted according to
present directives [5, 8, 19, 28, 32]. The altered vibratory sen-
sation, which was significantly frequent in this study (51.7%),
demonstrated a statistically significant association with the
risk of ulceration and amputation of the feet of DM patients
in the study of Parisi et al. [17].
A stratification in risk levels after arterial and neuro-
logical examinations on DM patients is recommended, so
as to correctly apply the adequate actions for each group,
aiming at implementing direct preventive measures for
DFU [5, 8, 32, 33]. In this study, adopting the classifica-
tion proposed by IWGDF, only 28.2% of the participants
were put on risk level 0, which is a frequency close to that
in the study of Almeida et al. (27.8%) [18]. A particular
study [14], which did not abide by the present directives
of the ABI [5, 8, 21], observed a prevalence of individuals
in low risk (risk level 0), varying from 56.0% to 79.8%.
The situation of possible failure in the detection of DM
patients which, conversely, is associated with elevated
risks, may delay the qualified professional in correctly
addressing the problem. It may, thus, lead to a greater risk
of the patient developing ulceration or later experiencing
amputation of their lower limbs.
The limitations of the current study included the use of
self-reported data, which may be underestimated when con-
cerned with the diagnosis of chronic complications, such as
functions of the lack of memory, or overestimated when con-
cerned with the practice of physical activity and foot care.
This paper reports limitations related to the use of self-
reported data during questionnaire administration, so they
may be underestimated with regard to the diagnosis of
chronic or overestimated complications regarding the prac-
tice of physical activity and foot care. Finally, a causal rela-
tionship could not be established between the dependent
and independent variables due to the cross-sectional design
of the research.
5. Conclusion
The study confirmed that the most frequent profile of DM
patients during treatment, here evaluated in the Brazilian
public health system, is specified by the following character-
istics: females with onychocutaneous alterations precursory
of ulcerations, individuals with low schooling levels, low
financial conditions, and low practice of physical exercise;
individuals diagnosed with DM for more than 10 years; indi-
viduals with systemic arterial hypertension, visual alterations,
dyslipidemia, loss of protective sensitivity of the feet, and ele-
vated risk of developing the DFU condition; and individuals
who did not undergo the physical examination of their feet
ever since the beginning of the treatment.
The risk factors that had a statistically significant associ-
ation with the development of DFU were the time since the
diagnosis of diabetes; appearance of the nails, humidity,
and deformities on the foot; and loss of protective sensation.
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